Topic resource collection
Approved comparison material connected to this topic.
3 resourcesRead both sides
BPC-157 VEGF upregulation, tight junction stabilization, enteric nervous system modulation 47+ animal studies; no human trials Subcutaneous or oral (enteric-coated) Requires -20°C storage; degrades in gastric acid without protect…
BPC-157 Promotes angiogenesis, upregulates VEGF and bFGF, accelerates mucosal healing 250–500mcg daily Once daily ~4 hours (requires daily dosing) Most evidence for direct GI tissue repair; studied extensively in colitis models T…
Before selecting peptides for IBD research protocols, understanding their distinct mechanisms, administration routes, and evidence quality clarifies which compound fits specific research goals. BPC-157 VEGF upregulation, FAK phos…